1 week ago
18
Soumya Eswaran
Mon, June 22, 2026 astatine 9:28 AM CDT 3 min read
Grow Funds, an concern Advisor, released its Q1 2026 capitalist missive for "GROW Small Cap Equity Long/Short Fund". A transcript of the missive tin beryllium downloaded here. In Q1 2026, GROW Small Cap Equity Long/Short L.P (Fund) returned 4.18%, outperforming the Russell 2000 Growth Index's –2.80%, HFRI Equity Hedge Index's -0.24%, and the HFRI Fundamental Growth Index's 0.47% returns. Long positions and hedges, and abbreviated positions, safeguarded the portfolio amid the volatility driven by the Iran War. In addition, delight cheque the Strategy's apical 5 holdings to cognize its champion picks successful 2026.
In its first-quarter 2026 capitalist letter, Grow Funds highlighted Profound Medical Corp. (NASDAQ:PROF). Profound Medical Corp. (NASDAQ:PROF) is simply a Canada based commercial-stage aesculapian instrumentality institution that focuses connected processing AI-powered, MRI-guided, incision-free therapeutic systems for the representation guided ablation of diseased tissue. On June 18, 2026, Profound Medical Corp. (NASDAQ:PROF) closed astatine $6.87 per share. One-month instrumentality of Profound Medical Corp. (NASDAQ:PROF) was 0.51%, and its shares gained 8.11% implicit the past 52 weeks. Profound Medical Corp. (NASDAQ:PROF) has a marketplace capitalization of $248.09 million.
Grow Funds stated the pursuing regarding Profound Medical Corp. (NASDAQ:PROF) successful its Q1 2026 capitalist letter:
"Profound Medical Corp. (NASDAQ:PROF) is simply a commercial-stage aesculapian instrumentality institution advancing incision-free, MRI-guided, and robotically-driven technologies to dainty prostate crab and benign prostatic hyperplasia (BPH). Their pb technology, TULSA-PRO®, utilizes real-time MRI and thermal ultrasound to precisely ablate prostate insubstantial portion preserving surrounding structures, aiming to minimize broadside effects similar incontinence and impotence. Profound presently has 78 systems astatine marque hospitals, with a pipeline of implicit 110 systems. Reimbursement to the infirmary is presently higher than competitory procedures. In addition, caller results from the Captain Trial show amended outcomes than extremist prostatectomy which is done chiefly utilizing the DaVinci robotic surgical strategy developed by Intuitive Surgical. Cook Medical and Siemens precocious introduced their caller iMRI suite, connected which TULSA-PRO procedures tin beryllium performed."
Profound Medical Corp. (NASDAQ:PROF) is not connected our database of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 6 hedge money portfolios held Profound Medical Corp. (NASDAQ:PROF) astatine the extremity of the archetypal quarter, compared to 10 successful the erstwhile quarter. While we admit the imaginable of Profound Medical Corp. (NASDAQ:PROF) arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.
English (CA) · 
English (US) · 
Spanish (MX) ·